Incentivizing living organ donation

Current Opinion in Organ Transplantation

Volumn 14, Issue 2, 2009, Pages 201-205

  Cynowiec, Jessica ^a   Kim, Jennifer ^a   Qazi, Yasir A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Donors; Incentives; Organ transplantation

Indexed keywords

COMPENSATION; HUMAN; KIDNEY DONOR; LEGAL ASPECT; MEDICAL ETHICS; ORGAN DONOR; ORGAN TRANSPLANTATION; REIMBURSEMENT; REVIEW; RISK ASSESSMENT; COMMERCIAL PHENOMENA; ECONOMICS; ETHICS; GOVERNMENT REGULATION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HOSPITAL ADMISSION; IRAN; LIVING DONOR; MOTIVATION; SOCIOECONOMICS; TRANSPLANTATION; UNITED STATES;

COMMERCE; COMPENSATION AND REDRESS; GOVERNMENT REGULATION; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; IRAN; LIVING DONORS; MOTIVATION; ORGAN TRANSPLANTATION; SOCIOECONOMIC FACTORS; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 67651031450     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283292582     Document Type: Review

References (32)

1. Annual Report of the Organ Procurement and Transplantation Network (OPTN/SRTR). http://www.ustransplant.org/annual-reports/current/106-dh.htm.
2. Larijani B, Sadeghi S, Jessri M, Zahedi F. Financial incentives in organ transplantation: ethical views. Iran J Allergy Asthma Immunol 2007; 6:39-45.
3. Becker GS, Elías JJ. Introducing incentives in the market for live and cadaveric organ donations. J Econ Perspect 2007; 21:3-24.
4. Fox MD. The price is wrong: the moral cost of living donor inducements. Am J Transplant 2006; 6:2529-2530.
5. National Organ Transplant Act (NOTA). Publ. No.98-507, Title 3 USC section #301 (g); 1984.
6. Ritsch ME. Intended recipient exchanges, paired exchanges and NOTA 301. Kidney and Pancreas Transplantation Committee report to OPTN/UNOS board of Directors. Richmond, VA: Williams Mullen; 2003.
7. Gaston RS, Danovitch GM, Epstein RA. Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant 2006; 6:2548-2555.
8. Magee CC, Pascual M. Update in renal transplantation. Arch Intern Med 2004; 164:1373-1388.
9. Weitz J, Koch M, Mehrabi A. Living-donor kidney transplantation: risks of the donor - benefits of the recipient. Clin Transplant 2006; 20:13-16. (Pubitemid 44697896)
10. Pace N. Transplantation: ethical and legal considerations. Anaesth Intensive Care Med 2006; 7:185-188.
11. Bruzzone P. Religious aspects of organ transplantation. Transplant Proc 2008; 40:1064-1067.
12. Scheper-Hughes N. The tyranny of the gift: sacrificial violence in living donor transplants. Am J Transplant 2007; 7:507-511. (Pubitemid 46376461)
13. Matas AJ. Why we should develop a regulated system of kidney sales: a call for action! Clin J Am Soc Nephrol 2006; 1:1129-1132.
14. Goyal M, Mehta R, Schneiderman L, Sehgal A. Economic and health consequences of selling a kidney in India. JAMA 2002; 288:1589-1593.
15. Boulware LE, Troll MU, Wang NY, Powe NR. Public attitudes toward incentives for organ donation: a national study of different racial/ethnic and income groups. Am J Transplant 2006; 6:2774-2785.
16. Danovitch GM, Leichtman AB. Kidney vending: the 'Trojan Horse' of organ transplantation. Clin J Am Soc Nephrol 2006; 1:1133-1135.
17. Bagheri A. Compensated kidney donation: an ethical review of the Iranian model. Kennedy Inst Ethics J 2006; 16:269-282. (Pubitemid 44621472)
18. Danovitch GM. From Helsinki to Istanbul: what can the transplant community learn from experience in clinical research? Nephrol Dial Transplant 2008; 23:1089-1092.
19. Israni AK, Halpern SD, Zink S. Incentive models to increase living kidney donation: encouraging without coercing. Am J Transplant 2005; 5:15-20. (Pubitemid 40095123)
20. Gaston RS, Danovitch GM, Epstein RA. Must all living donor compensation be viewed as valuable consideration? Am J Transplant 2007; 7: 1309-1310.
21. Klarenbach S, Garg AX, Vlaicu S. Living organ donors face financial barriers: a national reimbursement policy is needed. CMAJ 2006; 174:797-798.
22. Ghods AJ, Savaj S. Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol 2006; 1:1136-1145.
23. Hippen BE. Organ sales and moral travails: lessons from the living kidney vendor program in Iran. CATO Policy Analysis Series 2008; 614:1-17. An analysis of the Iranian model.
24. Malakoutian T, Hakemi MS, Nassiri AA. Socioeconomic status of Iranian living unrelated kidney donors: a multicenter study. Transplant Proc 2007; 39:824-825. (Pubitemid 46764940)
25. Mellstrom C, Johannesson M. Crowding out in blood donation: was Titmuss right? J Eur Econ Assoc 2008; 6:845-863.
26. Rothman SM, Rothman DJ. The hidden cost of organ sale. Am J Transplant 2006; 6:1524-1528.
27. Howard DH. Producing organ donors. J Econ Perspect 2007; 21:25-36.
28. Flamholz D. A penny for your organs: revising New York's policy on offering financial incentives for organ donation. J Law Policy 2006; 14:329-375.
29. Barshes NR, Horwitz IB, Franzini L. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant 2007; 7:1265-1270. (Pubitemid 46643109)
30. Ericzon BG, Larsson M, Wilczek HE. Domino liver transplantation: risks and benefits. Transplant Proc 2008; 40:1130-1131. (Pubitemid 351802222)
31. Gloor JM, Stegall MD. ABO incompatible kidney transplantation. Curr Opin Nephrol Hypertens 2007; 16:529-534.
32. Ross LF. The ethical limits in expanding living donor transplantation. Kennedy Inst Ethics J 2006; 16:151-172. (Pubitemid 44014939)